China Approves First Hemophilia B Gene Therapy by Belief BioMed and Takeda
April 11, 2025 | 15:39
Belief BioMed and Takeda China today jointly announced that BBM-H901, has been officially approved by the National Medical Products Administration for the treatment of adult patients with moderate to severe hemophilia B.
Latest News
Mobile Version
